Market revenue in 2023 | USD 5,428.7 million |
Market revenue in 2030 | USD 12,261.8 million |
Growth rate | 12.3% (CAGR from 2023 to 2030) |
Largest segment | Dna chips |
Fastest growing segment | Lab-on-chip |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tissue Arrays, Cell Arrays, DNA Chips, Lab-on-chip, Protein Chips |
Key market players worldwide | Agilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biochip market will help companies and investors design strategic landscapes.
Dna chips was the largest segment with a revenue share of 40.13% in 2024. Horizon Databook has segmented the North America biochip market based on tissue arrays, cell arrays, dna chips, lab-on-chip, protein chips covering the revenue growth of each sub-segment from 2018 to 2030.
North America held a significant share of the global biochip market, and its growth can be attributed to factors such as increasing efforts of pharmaceutical and biotechnology companies for drug development, advancement in proteomics, and growing demand for personalized medicine.
Moreover, the presence of a substantial number of players in the region and high investment in R&D related to precision medicine & advanced clinical diagnostics are some of the factors responsible for the largest revenue share of the region.
The presence of key market players such as Thermo Fisher Scientific, Illumina, and Agilent Technologies, which offer a broad range of microarrays for genotyping & gene expression applications, have supported North America’s dominance in the market in the past years.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America biochip market, including forecasts for subscribers. This continent databook contains high-level insights into North America biochip market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account